Last updated: 2026-09-16 09:04:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Revvity, Inc. (RVTY) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NYSE. The stock is currently priced at $140.48, with a market capitalisation of $14.34B and a P/E ratio of 65.85. Over the past 52 weeks, its price has ranged from $81.22 to $140.48. This page covers its latest market performance, valuation, price trends and company information.
$14.34B | |
$138.06 | |
$140.48 | |
$79.50 | |
$140.19 | |
-- | |
1.58M | |
65.85 | |
$140.48 | |
$81.22 | |
0.20% | |
-- |
Revvity, Inc. (RVTY) is trading at $140.48 in pre-market trading as of 2026-09-16 08:42:00, up 0.21% ($0.29) from the previous close of $140.19
Pre-market trading shows how investors are pricing RVTY before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Revvity, Inc. (RVTY) moved from $130.22 to $140.48, representing a gain of 7.88% ($10.26).
The stock traded between $120.90 and $140.48 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 1.81 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 100.0%
RVTY is currently trading at $140.48, placing it 100.0% of the way from its 52-week low of $81.22 to its 52-week high of $140.48. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 11000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Revvity, Inc. (RVTY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.